OrthoPediatrics’ updated analyst model now points to a price target of US$24.00, trimmed slightly from US$24.13, keeping the overall valuation framework in a similar dollar range. Analysts describe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results